Halozyme has completed its acquisition of Antares Pharma, Inc., creating a leading drug delivery business. View details here.
Inspiring
New
Inspiring
New
As of May 24, 2022, Halozyme completed its acquisition of Antares Pharma Inc., creating a leading drug delivery business with broadly licensable opportunities across the ENHANZE® and Antares’ auto injector technologies. View details here and send questions to info@staging-halozyme-staging.kinsta.cloud.
As of May 24, 2022, Halozyme completed its acquisition of Antares Pharma Inc., creating a leading drug delivery business with broadly licensable opportunities across the ENHANZE® and Antares’ auto injector technologies. View details here and send questions to info@staging-halozyme-staging.kinsta.cloud.
Inspiring New Approaches
At Halozyme, we continuously push the pace of innovation. Our technology facilitates the advancement of new and proven treatments and modalities for patients.
Inspiring New Possibilities
With our proprietary ENHANZE® drug delivery technology, we help develop therapies with differentiated characteristics – all with the intent of improving the experiences of our partners and our patients.
Inspiring New Options
Our ENHANZE® technology facilitates innovative new administration options for patients that can be given in a variety of settings
Inspiring New Partnerships
We collaborate with our partners to develop solutions to help improve patient experiences.